emoxypine succinate has been researched along with Hyperlipemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alekseev, MI; Koliadich, MI; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
| Miroshnichenko, IIu; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
1 trial(s) available for emoxypine succinate and Hyperlipemia
| Article | Year |
|---|---|
[Comparative study of alpha-lipoic acid and mexidol effects on affective status, cognitive functions and quality of life in diabetes mellitus patients].
Topics: Antioxidants; Attention; Cognition; Cognition Disorders; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Humans; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Lipid Peroxidation; Male; Middle Aged; Picolines; Placebos; Prospective Studies; Psychotropic Drugs; Quality of Life; Russia; Surveys and Questionnaires; Thioctic Acid | 2011 |
1 other study(ies) available for emoxypine succinate and Hyperlipemia
| Article | Year |
|---|---|
[Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].
Topics: Alloxan; Animals; Conditioning, Classical; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Female; Hyperglycemia; Hyperlipidemias; Hypoxia; Male; Meglumine; Mice; Nootropic Agents; Picolines; Pyridines; Rats; Succinates; Thioctic Acid | 2011 |